Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry
Open Access
- 12 May 2020
- journal article
- letter
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (9), 1974-1977
- https://doi.org/10.1182/bloodadvances.2020001664
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcomeHaematologica, 2016
- Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysisAutoimmunity Reviews, 2016
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in FranceBlood, 2014
- Hydroxychloroquine is a good second‐line treatment for adults with immune thrombocytopenia and positive antinuclear antibodiesAmerican Journal of Hematology, 2013
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood, 2011
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpuraAnnals of Hematology, 2008
- Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpuraJournal of Thrombosis and Thrombolysis, 2007
- Screening for Autoimmune Markers Is Unnecessary during Follow-up of Adults with Autoimmune Thrombocytopenic Purpura and no Autoimmune Markers at OnsetThrombosis and Haemostasis, 2000
- Range of antinuclear antibodies in “healthy” individualsArthritis & Rheumatism, 1997